ADMA BIOLOGICS, INC. 10-Q filing
Filed 2025-11-05 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001140361-25-040578
- Form type
- 10-Q
- CIK
- 0001368514
- Primary document
- https://www.sec.gov/Archives/edgar/data/1368514/000114036125040578/ef20054948_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADMA BIOLOGICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $371.0M | - | - |
| Cost Of Revenue | $167.1M | - | - |
| Gross Profit | $203.9M | - | - |
| Operating Income | $128.7M | - | - |
| Net Income | $97.6M | - | - |
| Eps Basic | 0.41 | - | - |
| Eps Diluted | 0.4 | - | - |
| Cash And Equivalents | $61.4M | - | - |
| Total Assets | $568.7M | - | - |
| Total Liabilities | $137.5M | - | - |
| Shareholders Equity | $431.2M | - | - |
| Operating Cash Flow | $14.8M | - | - |
| Capital Expenditures | $21.5M | - | - |